LSI is Officially Heading to Singapore — Register for LSI Asia '25 Today
Next registration rate increase: 
July 26, 5PM PT

Partner with the Leaders Building Medtech

September 16th - 20th | Penha Longa, The Ritz Carlton | Sintra, Portugal
Secure Your Spot Filling Fast

Apply to Present   icon

On-stage presentation to a full house of investors

Apply to Exhibit   icon

Private demo and partnering space in our Innovator Pavilion

Sponsorship Opportunities   icon

Elevate your brand at the epicenter of the industry

Trusted By The Companies Pioneering What’s Next

the Ethos of our events
World-class executives, convening in world-class venues to do real business

In 2023, LSI Europe convened 750 executives from emerging companies, venture capital and private equity firms, family offices, global strategics, professional service providers, and more

LSI Europe will never be held in a chaotic convention center. It is a curated forum where real business gets done, hosted in world-class venues where senior executives want to do business.

Speakers and Attendees

Industry-leading executives from emerging companies, venture capital and private equity firms, family offices, investment banks, global strategics, and more.

View all Attendees
Murielle Thinard McLane linkedin
Murielle Thinard McLane

Managing Partner

Intuitive Ventures

Antoine Papiernik linkedin
Antoine Papiernik

Chairman & Managing Partner

Sofinnova Partners

Gilad Glick linkedin
Gilad Glick

Vice President, Venture Investments - MedTech, JJDC

Johnson & Johnson

Carissa Black linkedin
Carissa Black

Senior Director, Venture Capital

Medtronic

Alan Cohen linkedin
Alan Cohen

General Partner

DCVC

Todd Brinton linkedin
Todd Brinton

Board Director, Stanford Biodesign and Co-Founder, Shockwave

Chief Scientific Officer, Edwards Lifesciences

Diana Saraceni linkedin
Diana Saraceni

Co-Founder & General Partner

Panakes Partners

Josh Makower linkedin
Josh Makower

Director & Co-Founder, Stanford Byers Center for Biodesign

Venture Partner, Sofinnova Partners

Present at LSI Europe ‘24
LSI Europe ‘24
Presenting Companies

Present to a full house of investors and strategics alongside the CEOs and Founders building technology that is shaping the future of healthcare.

  • Azalea Vision

    Presenter

    Azalea Vision arrow
    arrow
    Enrique Vega

    CEO

    Azalea Vision is developing a solution for patients with conditions and disorders that increase sensitivity to light. The company's solution actively adapts and manages within a personalized contact lens. The lens will also be capable of compensating for refractive errors of the eye, such as astigmatism and myopia. Visit website.

    Promaxo

    Presenter

    Promaxo arrow
    arrow
    Amit Vohra

    Founder, President & CEO

    Next generation office-based modular MRI and MRI based technologies. Initial focus on advancing the solutions for prostate disease management and other urology and pelvic conditions. Visit website.

    CAPS Medical

    Presenter

    CAPS Medical arrow
    arrow
    Ilan Uchitel

    CEO

    CAPS Medical is developing a solution to treat a wide range of solid tumors using Non-thermal Atmospheric Plasma (NTAP). This minimally invasive procedure selectively destroys cancer cells without damaging the surrounding healthy tissue.  Visit website.

    NovaResp Technologies

    Presenter

    NovaResp Technologies arrow
    arrow
    Hamed Hanafi

    President & CEO

    NovaResp is developing technology to improve the prediction of respiratory events in patients using positive airway pressure (PAP) machines. The company's platform uses artificial intelligence and machine learning to monitor respiration and prevent detrimental episodes of apnea.  Visit website.

    Ditch Labs

    Presenter

    Ditch Labs arrow
    arrow
    Laurent Laferriere

    Co-Founder & CEO

    Ditch Labs is an early-stage startup developing a digital platform for the treatment of substance abuse disorders. The platform uses software/device combination to address the physiological and psychological addiction concurrently. The platform is initially being developed for the treatment of smoking cessation/nicotine addiction using the DitchPen medical vaporizer that pairs with a digital therapeutic that learns, adapts, and assists patients through the withdrawal process. Visit website.

    Kelvin Health

    Presenter

    Kelvin Health arrow
    arrow
    Georgi Kadrev

    Co-Founder & CEO

    Kelvin Health uses a mobile thermal imaging camera to capture the head of the body and then analyzes those images with AI to detect anomalies related to vascular conditions. The company's technology offers new insights intended to improve the management of patients with vascular diseases.  Visit website.

    Novuson Surgical

    Presenter

    Novuson Surgical arrow
    arrow
    Stuart Mitchell

    Founder/CEO

    Novuson’s patented DTU technology will represent the first substantive innovation in over 25 years for targeting vessel sealing / dividing, and hemostasis (bleeding control) in surgical and trauma applications. Visit website.

    Oxford Endovascular

    Presenter

    Oxford Endovascular arrow
    arrow
    Mike Karim

    CEO

    Having been spun-out from Oxford University, Oxford Endovascular is developing OxiFlow, a next-generation flow-diverter to reduce the risk of complications and ruptures in patients with intracranial aneurysms. Visit website.

    Solenic Medical

    Presenter

    Solenic Medical arrow
    arrow
    James Lancaster

    CEO

    Solenic Medical is developing a non-invasive medical device that utilizes alternating magnetic fields to eradicate biofilms that form on implants. The company's platform uses external magnetic coils to destroy infective biofilms on the surface of knee and hi replacement implants, as well as plates and rods for trauma related procedures. Solenic's solution is being developed to replace the expensive and risky two-step revision surgery, which is the current standard of care for chronic infections on medical implants. Visit website.

    OncoHost

    Presenter

    OncoHost arrow
    arrow
    Ofer Sharon

    CEO

    OncoHost aims to help providers and patients understand a patient's unique response to cancer therapies. The PROphet platform combines bioinformatics, system biology, proteomic pattern recognition, and machine learning to provide clinicians with actional clinical insights to optimize patient therapy.  Visit website.

    Polimerbio

    Presenter

    Polimerbio arrow
    arrow
    Pablo Fernandez Echeverria

    CEO

    Polimerbio is focused on the research, development, and manufacture of biodegradable medical devices based on the company's extensive knowledge and experience in polymer chemistry. Within the company's portfolio of products in development are a biodegradable stent for the treatment of urethral stricture and scaffolds for the regeneration of spinal cord injuries. Visit website.

    Keyron

    Presenter

    Keyron arrow
    arrow
    Giorgio Castagneto Gissey

    CEO

    Keyron Medical is an early-stage medtech company focused on treating Type 2 diabetes, NASH, and obesity, in addition to other metabolic diseases. The company's ForePass device features an innovative design that enables a non-invasive bypass at the duodenal level. The device is inserted via endoscopy without requiring a single incision, thereby allowing the device to avoid the risks of traditional gastric bypass surgery. In animal models, the device has been shown to completely reverse Type 2 diabetes. Visit website.

  • VeinWay

    Presenter

    VeinWay arrow
    arrow
    Jordan Pollack

    CEO

    VeinWay is addressing the challenges in treating venous chronic total occlusions. Crossing veins is currently a time-consuming endeavor that remains challenging enough for failures to occur. The company's Traversa catheter has been designed to penetrate blockages with its unique features, including: a steerable needle to maintain navigational control, a 6mm balloon that anchors the device to enhance needle penetration, and a braided catheter that balances catheter strength and flexibility. Visit website.

    CairnSurgical

    Presenter

    CairnSurgical arrow
    arrow
    David Danielsen

    CEO

    CairnSurgical is developing an innovative tool to guide surgical interventions in patients with cancer. The company's Breast Cancer Locator (BCL) is a proprietary, patient-specific, 3D printed surgical guide intended to reduce positive margins during breast cancer tumor removal. The solution uses MRI data to create a personalized model that assist surgeons in localization and excision of tumors to reduce positive margins. Visit website.

    ConnCons

    Presenter

    ConnCons arrow
    arrow
    Jochen Hampe

    CEO

    ConnCons integrates connectivity into infusion consumables to create a cloud to vessel end-to-end digital solution. The system enables safer, faster and automated therapies with a superior patient experience. First clinical applications are targeted at both center-based and home oncological therapy. Visit website.

    THERYQ

    Presenter

    THERYQ arrow
    arrow
    Ludovic Le Meunier

    CEO

    THERYQ specializes in the design and production of linear accelerators for radiotherapy. The company's FLASH technology is intended to increase the effectiveness of radiotherapy, by taking the conventional radiotherapy process requiring multiple treatment sessions and weeks of irradiation and condensing it into a single procedure performed in milliseconds. The result of this high energy radiotherapy is a reduction in the side effects while simultaneously increasing treatment efficacy. Visit website.

    Vitestro

    Presenter

    Vitestro arrow
    arrow
    Toon Overbeeke

    Co-Founder & CEO

    Vitestro is developing an autonomous platform for drawing blood. The company's device combines AI-based, ultrasound-guided 3D reconstruction with robotic needle insertion to insure accurate and secure blood collection.  Visit website.

    Acorai

    Presenter

    Acorai arrow
    arrow
    Filip Peters

    CEO

    Acorai is developing a non-invasive monitoring solution to measure pulmonary artery pressure. The handheld device utilizes a unique combination of acoustic, electrocardiographic, pressure, seismic and visual sensors to collect robust data to be analyzed using a machine learning engine to evaluate heart failure progression. The company's solution is an alternative to the current standard procedure, which involves right heart catheterization performed in a catheterization lab to evaluate heart functionality. Visit website.

    Aqua Medical

    Presenter

    Aqua Medical arrow
    arrow
    Lloyd Mencinger

    President & CEO

    Treating type 2 diabetes and GI disease with 30 minute, out-patient, endoscopic ablation therapy Visit website.

    FeelTect

    Presenter

    FeelTect arrow
    arrow
    Andrew Cameron

    CEO

    FeelTect's Tight Alright is a connect-health platform that provides data-driven, targeted, and consistent compression therapy for the treatment of venous leg ulcers. The solution employs a point-of-care wearable pressure sensing device that optimizes traditional compression therapy to reduce healing time, frequencies in healthcare visits, and costs to treat. Visit website.

    TecTraum

    Presenter

    TecTraum arrow
    arrow
    John Zak

    President and CEO

    TecTraum has designed and developed a novel medical device for the treatment of concussions. The company's pro2Cool device is a non-invasive, portable system that delivers hypothermic therapy to the head and neck to reduce the impact and symptoms of traumatic brain injuries. TecTraum has received Breakthrough Device Designation from the U.S. FDA for pro2cool. The company has submitted a de novo filing for consideration for market authorization with the FDA that is currently under review. Visit website.

    SentiAR

    Presenter

    SentiAR arrow
    arrow
    Berk Tas

    CEO

    Transforming the experience for both patient and clinician in interventional procedures with a 3D augmented reality platform featuring real-time holographic visualization of the patient’s actual anatomy, “floating” over the patient. Visit website.

    TAE Life Sciences

    Presenter

    TAE Life Sciences arrow
    arrow
    Rob Hill

    CEO

    TAE Life Sciences, a subsidiary of TAE Technologies, is leveraging accelerator-based neutron beam technology for Boron Neutron Capture Therapy (BNCT) to bring promising treatment potential for head and neck, glioblastoma multiforme (GBM) and other cancers that are difficult to treat with traditional methods.  Visit website.

    CorNeat Vision

    Presenter

    CorNeat Vision arrow
    arrow
    Almog Aley-Raz

    CEO

    CorNeat Vision has developed a proprietary platform for developing nondegradable, biomimetic biomaterials to treat diseases. The company's EverMAtrix material is a 100% synthetic, nondegradable porous material that mimics the micro-structure of the extracellular matric (ECM). CorNeat's technology has been applied to products for dental and ophthalmic surgery.  Visit website.

  • BrainSpace

    Presenter

    BrainSpace arrow
    arrow
    Caitlin Morse

    CEO

    BrainSpace is developing a solution to simplify critical care in neurocritical patients. BrainSpace is committed to improving the way brain pressure is managed in patients recovering from stroke, traumatic brain injury, and neurosurgery. Currently patients requiring intracranial pressure management must be meticulously monitored and measured hourly by a nurse. The company has developed an automated monitoring solution as an alternative to the antiquated drainage monitoring relying on a manometer-based drain and blood pressure monitor that eliminates the hassle for patients and providers while improving the quality of data being captured for researchers and physicians. Visit website.

    Centese

    Presenter

    Centese arrow
    arrow
    Evan Luxon

    CEO

    Transforming surgical drainage with intelligent digital devices to reduce complications and costs in patients recovering from cardiothoracic surgery. Visit website.

    Aortyx

    Presenter

    Aortyx arrow
    arrow
    Jordi Martorell

    CEO & Co-Founder

    Aortyx is developing a solution for the treatment of aortic dissection. The company is developing a biomimetic, bioresorbable endovascular patch that is deployed via an endovascular catheter. The patch is designed to cover an aortic tear, stop false lumen blood flow, and promote natural repair and bio-integration at the tear site.  Visit website.

    Pristine Surgical

    Presenter

    Pristine Surgical arrow
    arrow
    Bryan Lord

    CEO

    Pristine Surgical makes a high definition single-use visualization system for minimally invasive surgery and delivers its visualization devices in complete single-use kits. The devices utilize a low-cost image processing unit which also serves as a portal to cloud-based software supporting the entire surgical episode. Visit website.

    Vektor Medical

    Presenter

    Vektor Medical arrow
    arrow
    Rob Krummen

    CEO

    Vektor Medical's vMAP system helps identify the sources of stable and unstable arrhythmia using accessible, noninvasive electrocardiogram (ECG) data. Clinicians upload ECG data into the vMAP system, which then interprets and visualizes the data in 3D to identify sources of arrhythmia inside and outside of the heart. The FDA-cleared  vMAP system is capable of creating a "heat map" of the heart in < 3 minutes to support or improve ablation treatment planning. Visit website.

    InVera Medical

    Presenter

    InVera Medical arrow
    arrow
    Stephen Cox

    CEO

    InVera Medical is developing a catheter-based therapy for chronic venous disease.  The device uses non-thermal energy to disrupts the inner vessel lining, resulting in natural scarring and vessel closure that diverts blood flow away from diseased vessels. Visit website.

    Kent Imaging

    Presenter

    Kent Imaging arrow
    arrow
    Pierre Lemire

    CEO

    Kent Imaging is using multispectral oxygenation imaging to enhance the care of chronic wounds. The company's lead product, SnapshotNIR, is a portable tool that utilizes near-infrared (NIR), reflectance-based technology to measure tissue oxygen saturation in superficial tissue. The information collected by the device improves the data available to care providers when making medical decisions that positively impact patient outcomes in wound care. Visit website.

    Interventional Systems

    Presenter

    Interventional Systems arrow
    arrow
    Pedro Costa

    CEO

    Interventional Systems develops B2B and OEM surgical robotic platform solutions for minimally invasive surgery and percutaneous interventions. The company partners with other medical device manufacturers to offer them a customizable CE-Marked, FDA Cleared robotic platform that the partners can commercialize in combination with their therapeutic products (such as implants, needles, guidewires, etc.). Interventional Systems establishes and maintains the whole enabling processes and operations related to a robotics program, allowing the partner to focus on the commercialization efforts. Visit website.

    Affluent Medical

    Presenter

    Affluent Medical arrow
    arrow
    Sebastien Ladet

    CEO

    Affluent Medical is a next-generation prostheses developer building a portfolio of therapies for the treatment of cardiovascular and urological diseases. The company's cardiovascular products consist of the Kalios annuloplasty device that can be adjusted percutaneously and the Epygon, a bio-prosthesis for transapical mitral valve replacement. To address stress urinary incontinence, the company is developing Artus, a remote-controlled implant that returns control of voiding to patients suffering from this condition. Visit website.

    Happitech

    Presenter

    Happitech arrow
    arrow
    Yosef Safi Harb

    Founder and CEO

    Happitech has developed a CE-marked, smartphone-based method for effective remote monitoring of patients. The company's core competencies in artificial intelligence (AI) integration and photoplethysmography (PPG) enable effective and accurate measurement of heart rate and atrial fibrillation. Visit website.

    Hy2Care

    Presenter

    Hy2Care arrow
    arrow
    Leo Smit

    CEO

    Hy2Care's vision is to support patients in the fight against osteoarthritis. The company's lead product, CartRevive, is a hydrogel implant composed of dextran and hyaluronic acid conjugates that form a resorbable scaffold when injected. The hydrogel enables natural restoration of tissue defects by creating an environment conducive to cell regrowth that proceeds towards the restoration of smooth hyaline cartilage.  Visit website.

    Hypervision Surgical

    Presenter

    Hypervision Surgical arrow
    arrow
    Michael Ebner

    CEO & Co-Founder

    Hypervision Surgical is developing an AI-driven intraoperative imaging system for wide-field tissue differentiation to identify normal tissue, nerves, blood vessels and tumors in real time. The technology is non-invasive, non-contact and does not require the use of exogenous contrast agent.  Visit website.

  • ATRO Medical

    Presenter

    ATRO Medical arrow
    arrow
    Anita Brinks

    COO

    ATRO Medical's Artimis prosthesis is intended to provide patients who are too young for a knee replacement yet suffering from chronic knee pain with a viable solution. Artimis is a flexible, artificial meniscus that offers patients a less invasive alternative for treating chronic knee pain. Visit website.

    Arga Medtech

    Presenter

    Arga Medtech arrow
    arrow
    David Neale

    CEO

    Arga Medtech is developing a next-generation solution for the treatment of cardiac arrhythmia and atrial fibrillation. The company's Coherent Sine-burst Electroporation (CSE) uses a proprietary puled-field ablation (PFA) generator and catheter to offer a single-shot device capable of producing linear and focal lesions safer, more efficiently and faster than existing technologies used to treat cardiac arrhythmias today. Visit website.

    Radiance Therapeutics

    Presenter

    Radiance Therapeutics arrow
    arrow
    Laurence Marsteller

    CEO

    Next-generation beta ophthalmic applicator. Visit website.

    INNITIUS

    Presenter

    INNITIUS arrow
    arrow
    Ruben Molina

    CEO and Co-Founder

    INNITIUS is a medical device startup that develops a new technology (Torsional Waves) for the numerical and objective quantification of cervical consistency. This technology is reproducible between different users and, in combination with diagnostic algorithms that include this variable together with other clinical history variables, will be used for the diagnosis of any pathology related to changes in the consistency of cervical tissue in women in the different stages of life globally. The first pathology targeted by the company is the diagnosis of Threatened Preterm Labor. Visit website.

    NIMBLE

    Presenter

    NIMBLE arrow
    arrow
    Oriol Iborra

    CEO & Co-Founder

    Every year, 4M new coronary stents are implanted to maintain the arteries’ functionality of patients who suffered a heart attack. However, 30% of these stents will fail within two years, and the sole method available to cardiologists to monitor stent malfunction is an angiogram—an invasive and ionizing procedure performed during surgery. We introduce the NIMBLE System, a first-in-class, non-invasive, non-ionizing microwave-based technology that enables cardiologists to obtain objective data about the status of coronary stents. This includes level of occlusion, potential fractures, or migrations that could endanger patients' lives. NIMBLE addresses a massive blue ocean market of $8 billion, allowing cardiologists to take control of their patients with heart failure, providing objective data through a convenient, non-invasive technology, aiming to save millions of lives. Visit website.

    Coramaze Technologies

    Presenter

    Coramaze Technologies arrow
    arrow
    Jochen Reinöhl

    CEO

    Coramaze Technologies is developing an fast end effective solution for the treatment of tricuspid regurgitation. The TriPair system is deigned to be anchored atraumatically to the right atrium. The device is intended to be easily placed in a procedure taking less than twenty minutes, without the need for anesthesia or TEE. TriPair is agnostic of valve morphology and can be retrieved if necessary Visit website.

    Twinical

    Presenter

    Twinical arrow
    arrow
    Mario Arico

    CEO & Co-Founder

    Twinical is developing a novel solution for soft-tissue surgical planning and navigation. The company's technology combines artificial intelligence and augmented reality to provide surgeons with digitally-enhanced visual guidance during surgery. Visit website.

    Sonic Incytes

    Presenter

    Sonic Incytes arrow
    arrow
    Barry Allen

    President & CEO

    Sonic Incytes' Velacur is a portable, handheld ultrasound that integrates machine learning to enhance image guidance, resulting in a confident assessment of liver health in all body types. Scans using the Velacur system can be performed in the physician office in approximately 5 minutes, producing real-time measurements of liver stiffness and attenuation.  Visit website.

    Preventicus

    Presenter

    Preventicus arrow
    arrow
    Adriann Hart de Ruijter

    Chairman

    Preventicus provides managed care programs and technology for cardiovascular disease through early detection, diagnosis and monitoring. Innovative telecare technology, clinical evidence and proven health-economic outcomes, in compliance with medical guidelines, offer value to patients and health insurances Visit website.

    machineMD

    Presenter

    machineMD arrow
    arrow
    Dominic Senn

    CEO

    MachineMD’s focus is the creation of automated, quantifiable, and standardized medical examinations to improve the quality and efficiency of healthcare. The company’s mission is to bring the diagnostic quality of trained tertiary care specialists into secondary and primary care sites for the diagnosis and monitoring of neurological disorders. At the core of the company’s approach is the evaluation of biomarkers related to eye movements and pupillary function using artificial intelligence and virtual reality.  Visit website.

    Methinks AI

    Presenter

    Methinks AI arrow
    arrow
    Pau Rodriguez

    CEO

    Methinks vision is to provide universal and timely medical assistance to enable life-saving treatments worldwide. The company is initially focused on stroke, the second most common cause of death and a major cause of disability globally. Its AI software, Methinks Stroke Suite, is capable of assisting in stroke triage and providing decision support for life-saving treatment using the simplest medical imaging (non-contrast CT), with the potential to optimize stroke triage and reduce time to treatment. Visit website.

    Caresyntax

    Presenter

    Caresyntax arrow
    arrow
    Bjoern von Siemens

    Founder, CFO

    For industry partners bringing innovative solutions to market: Caresyntax offers clinical data services, data science expertise, and AI-enabled tech modules to collect meaningful data straight from the point of care. The company's services capture value for the end-user and produce actionable insights to drive commercial growth and product development needs. Visit website.

Azalea Vision

Presenter

Azalea Vision arrow
arrow
Enrique Vega

CEO

Azalea Vision is developing a solution for patients with conditions and disorders that increase sensitivity to light. The company's solution actively adapts and manages within a personalized contact lens. The lens will also be capable of compensating for refractive errors of the eye, such as astigmatism and myopia. Visit website.

Promaxo

Presenter

Promaxo arrow
arrow
Amit Vohra

Founder, President & CEO

Next generation office-based modular MRI and MRI based technologies. Initial focus on advancing the solutions for prostate disease management and other urology and pelvic conditions. Visit website.

CAPS Medical

Presenter

CAPS Medical arrow
arrow
Ilan Uchitel

CEO

CAPS Medical is developing a solution to treat a wide range of solid tumors using Non-thermal Atmospheric Plasma (NTAP). This minimally invasive procedure selectively destroys cancer cells without damaging the surrounding healthy tissue.  Visit website.

NovaResp Technologies

Presenter

NovaResp Technologies arrow
arrow
Hamed Hanafi

President & CEO

NovaResp is developing technology to improve the prediction of respiratory events in patients using positive airway pressure (PAP) machines. The company's platform uses artificial intelligence and machine learning to monitor respiration and prevent detrimental episodes of apnea.  Visit website.

Ditch Labs

Presenter

Ditch Labs arrow
arrow
Laurent Laferriere

Co-Founder & CEO

Ditch Labs is an early-stage startup developing a digital platform for the treatment of substance abuse disorders. The platform uses software/device combination to address the physiological and psychological addiction concurrently. The platform is initially being developed for the treatment of smoking cessation/nicotine addiction using the DitchPen medical vaporizer that pairs with a digital therapeutic that learns, adapts, and assists patients through the withdrawal process. Visit website.

Kelvin Health

Presenter

Kelvin Health arrow
arrow
Georgi Kadrev

Co-Founder & CEO

Kelvin Health uses a mobile thermal imaging camera to capture the head of the body and then analyzes those images with AI to detect anomalies related to vascular conditions. The company's technology offers new insights intended to improve the management of patients with vascular diseases.  Visit website.

Novuson Surgical

Presenter

Novuson Surgical arrow
arrow
Stuart Mitchell

Founder/CEO

Novuson’s patented DTU technology will represent the first substantive innovation in over 25 years for targeting vessel sealing / dividing, and hemostasis (bleeding control) in surgical and trauma applications. Visit website.

Oxford Endovascular

Presenter

Oxford Endovascular arrow
arrow
Mike Karim

CEO

Having been spun-out from Oxford University, Oxford Endovascular is developing OxiFlow, a next-generation flow-diverter to reduce the risk of complications and ruptures in patients with intracranial aneurysms. Visit website.

Solenic Medical

Presenter

Solenic Medical arrow
arrow
James Lancaster

CEO

Solenic Medical is developing a non-invasive medical device that utilizes alternating magnetic fields to eradicate biofilms that form on implants. The company's platform uses external magnetic coils to destroy infective biofilms on the surface of knee and hi replacement implants, as well as plates and rods for trauma related procedures. Solenic's solution is being developed to replace the expensive and risky two-step revision surgery, which is the current standard of care for chronic infections on medical implants. Visit website.

OncoHost

Presenter

OncoHost arrow
arrow
Ofer Sharon

CEO

OncoHost aims to help providers and patients understand a patient's unique response to cancer therapies. The PROphet platform combines bioinformatics, system biology, proteomic pattern recognition, and machine learning to provide clinicians with actional clinical insights to optimize patient therapy.  Visit website.

Polimerbio

Presenter

Polimerbio arrow
arrow
Pablo Fernandez Echeverria

CEO

Polimerbio is focused on the research, development, and manufacture of biodegradable medical devices based on the company's extensive knowledge and experience in polymer chemistry. Within the company's portfolio of products in development are a biodegradable stent for the treatment of urethral stricture and scaffolds for the regeneration of spinal cord injuries. Visit website.

Keyron

Presenter

Keyron arrow
arrow
Giorgio Castagneto Gissey

CEO

Keyron Medical is an early-stage medtech company focused on treating Type 2 diabetes, NASH, and obesity, in addition to other metabolic diseases. The company's ForePass device features an innovative design that enables a non-invasive bypass at the duodenal level. The device is inserted via endoscopy without requiring a single incision, thereby allowing the device to avoid the risks of traditional gastric bypass surgery. In animal models, the device has been shown to completely reverse Type 2 diabetes. Visit website.

VeinWay

Presenter

VeinWay arrow
arrow
Jordan Pollack

CEO

VeinWay is addressing the challenges in treating venous chronic total occlusions. Crossing veins is currently a time-consuming endeavor that remains challenging enough for failures to occur. The company's Traversa catheter has been designed to penetrate blockages with its unique features, including: a steerable needle to maintain navigational control, a 6mm balloon that anchors the device to enhance needle penetration, and a braided catheter that balances catheter strength and flexibility. Visit website.

CairnSurgical

Presenter

CairnSurgical arrow
arrow
David Danielsen

CEO

CairnSurgical is developing an innovative tool to guide surgical interventions in patients with cancer. The company's Breast Cancer Locator (BCL) is a proprietary, patient-specific, 3D printed surgical guide intended to reduce positive margins during breast cancer tumor removal. The solution uses MRI data to create a personalized model that assist surgeons in localization and excision of tumors to reduce positive margins. Visit website.

ConnCons

Presenter

ConnCons arrow
arrow
Jochen Hampe

CEO

ConnCons integrates connectivity into infusion consumables to create a cloud to vessel end-to-end digital solution. The system enables safer, faster and automated therapies with a superior patient experience. First clinical applications are targeted at both center-based and home oncological therapy. Visit website.

THERYQ

Presenter

THERYQ arrow
arrow
Ludovic Le Meunier

CEO

THERYQ specializes in the design and production of linear accelerators for radiotherapy. The company's FLASH technology is intended to increase the effectiveness of radiotherapy, by taking the conventional radiotherapy process requiring multiple treatment sessions and weeks of irradiation and condensing it into a single procedure performed in milliseconds. The result of this high energy radiotherapy is a reduction in the side effects while simultaneously increasing treatment efficacy. Visit website.

Vitestro

Presenter

Vitestro arrow
arrow
Toon Overbeeke

Co-Founder & CEO

Vitestro is developing an autonomous platform for drawing blood. The company's device combines AI-based, ultrasound-guided 3D reconstruction with robotic needle insertion to insure accurate and secure blood collection.  Visit website.

Acorai

Presenter

Acorai arrow
arrow
Filip Peters

CEO

Acorai is developing a non-invasive monitoring solution to measure pulmonary artery pressure. The handheld device utilizes a unique combination of acoustic, electrocardiographic, pressure, seismic and visual sensors to collect robust data to be analyzed using a machine learning engine to evaluate heart failure progression. The company's solution is an alternative to the current standard procedure, which involves right heart catheterization performed in a catheterization lab to evaluate heart functionality. Visit website.

Aqua Medical

Presenter

Aqua Medical arrow
arrow
Lloyd Mencinger

President & CEO

Treating type 2 diabetes and GI disease with 30 minute, out-patient, endoscopic ablation therapy Visit website.

FeelTect

Presenter

FeelTect arrow
arrow
Andrew Cameron

CEO

FeelTect's Tight Alright is a connect-health platform that provides data-driven, targeted, and consistent compression therapy for the treatment of venous leg ulcers. The solution employs a point-of-care wearable pressure sensing device that optimizes traditional compression therapy to reduce healing time, frequencies in healthcare visits, and costs to treat. Visit website.

TecTraum

Presenter

TecTraum arrow
arrow
John Zak

President and CEO

TecTraum has designed and developed a novel medical device for the treatment of concussions. The company's pro2Cool device is a non-invasive, portable system that delivers hypothermic therapy to the head and neck to reduce the impact and symptoms of traumatic brain injuries. TecTraum has received Breakthrough Device Designation from the U.S. FDA for pro2cool. The company has submitted a de novo filing for consideration for market authorization with the FDA that is currently under review. Visit website.

SentiAR

Presenter

SentiAR arrow
arrow
Berk Tas

CEO

Transforming the experience for both patient and clinician in interventional procedures with a 3D augmented reality platform featuring real-time holographic visualization of the patient’s actual anatomy, “floating” over the patient. Visit website.

TAE Life Sciences

Presenter

TAE Life Sciences arrow
arrow
Rob Hill

CEO

TAE Life Sciences, a subsidiary of TAE Technologies, is leveraging accelerator-based neutron beam technology for Boron Neutron Capture Therapy (BNCT) to bring promising treatment potential for head and neck, glioblastoma multiforme (GBM) and other cancers that are difficult to treat with traditional methods.  Visit website.

CorNeat Vision

Presenter

CorNeat Vision arrow
arrow
Almog Aley-Raz

CEO

CorNeat Vision has developed a proprietary platform for developing nondegradable, biomimetic biomaterials to treat diseases. The company's EverMAtrix material is a 100% synthetic, nondegradable porous material that mimics the micro-structure of the extracellular matric (ECM). CorNeat's technology has been applied to products for dental and ophthalmic surgery.  Visit website.

BrainSpace

Presenter

BrainSpace arrow
arrow
Caitlin Morse

CEO

BrainSpace is developing a solution to simplify critical care in neurocritical patients. BrainSpace is committed to improving the way brain pressure is managed in patients recovering from stroke, traumatic brain injury, and neurosurgery. Currently patients requiring intracranial pressure management must be meticulously monitored and measured hourly by a nurse. The company has developed an automated monitoring solution as an alternative to the antiquated drainage monitoring relying on a manometer-based drain and blood pressure monitor that eliminates the hassle for patients and providers while improving the quality of data being captured for researchers and physicians. Visit website.

Centese

Presenter

Centese arrow
arrow
Evan Luxon

CEO

Transforming surgical drainage with intelligent digital devices to reduce complications and costs in patients recovering from cardiothoracic surgery. Visit website.

Aortyx

Presenter

Aortyx arrow
arrow
Jordi Martorell

CEO & Co-Founder

Aortyx is developing a solution for the treatment of aortic dissection. The company is developing a biomimetic, bioresorbable endovascular patch that is deployed via an endovascular catheter. The patch is designed to cover an aortic tear, stop false lumen blood flow, and promote natural repair and bio-integration at the tear site.  Visit website.

Pristine Surgical

Presenter

Pristine Surgical arrow
arrow
Bryan Lord

CEO

Pristine Surgical makes a high definition single-use visualization system for minimally invasive surgery and delivers its visualization devices in complete single-use kits. The devices utilize a low-cost image processing unit which also serves as a portal to cloud-based software supporting the entire surgical episode. Visit website.

Vektor Medical

Presenter

Vektor Medical arrow
arrow
Rob Krummen

CEO

Vektor Medical's vMAP system helps identify the sources of stable and unstable arrhythmia using accessible, noninvasive electrocardiogram (ECG) data. Clinicians upload ECG data into the vMAP system, which then interprets and visualizes the data in 3D to identify sources of arrhythmia inside and outside of the heart. The FDA-cleared  vMAP system is capable of creating a "heat map" of the heart in < 3 minutes to support or improve ablation treatment planning. Visit website.

InVera Medical

Presenter

InVera Medical arrow
arrow
Stephen Cox

CEO

InVera Medical is developing a catheter-based therapy for chronic venous disease.  The device uses non-thermal energy to disrupts the inner vessel lining, resulting in natural scarring and vessel closure that diverts blood flow away from diseased vessels. Visit website.

Kent Imaging

Presenter

Kent Imaging arrow
arrow
Pierre Lemire

CEO

Kent Imaging is using multispectral oxygenation imaging to enhance the care of chronic wounds. The company's lead product, SnapshotNIR, is a portable tool that utilizes near-infrared (NIR), reflectance-based technology to measure tissue oxygen saturation in superficial tissue. The information collected by the device improves the data available to care providers when making medical decisions that positively impact patient outcomes in wound care. Visit website.

Interventional Systems

Presenter

Interventional Systems arrow
arrow
Pedro Costa

CEO

Interventional Systems develops B2B and OEM surgical robotic platform solutions for minimally invasive surgery and percutaneous interventions. The company partners with other medical device manufacturers to offer them a customizable CE-Marked, FDA Cleared robotic platform that the partners can commercialize in combination with their therapeutic products (such as implants, needles, guidewires, etc.). Interventional Systems establishes and maintains the whole enabling processes and operations related to a robotics program, allowing the partner to focus on the commercialization efforts. Visit website.

Affluent Medical

Presenter

Affluent Medical arrow
arrow
Sebastien Ladet

CEO

Affluent Medical is a next-generation prostheses developer building a portfolio of therapies for the treatment of cardiovascular and urological diseases. The company's cardiovascular products consist of the Kalios annuloplasty device that can be adjusted percutaneously and the Epygon, a bio-prosthesis for transapical mitral valve replacement. To address stress urinary incontinence, the company is developing Artus, a remote-controlled implant that returns control of voiding to patients suffering from this condition. Visit website.

Happitech

Presenter

Happitech arrow
arrow
Yosef Safi Harb

Founder and CEO

Happitech has developed a CE-marked, smartphone-based method for effective remote monitoring of patients. The company's core competencies in artificial intelligence (AI) integration and photoplethysmography (PPG) enable effective and accurate measurement of heart rate and atrial fibrillation. Visit website.

Hy2Care

Presenter

Hy2Care arrow
arrow
Leo Smit

CEO

Hy2Care's vision is to support patients in the fight against osteoarthritis. The company's lead product, CartRevive, is a hydrogel implant composed of dextran and hyaluronic acid conjugates that form a resorbable scaffold when injected. The hydrogel enables natural restoration of tissue defects by creating an environment conducive to cell regrowth that proceeds towards the restoration of smooth hyaline cartilage.  Visit website.

Hypervision Surgical

Presenter

Hypervision Surgical arrow
arrow
Michael Ebner

CEO & Co-Founder

Hypervision Surgical is developing an AI-driven intraoperative imaging system for wide-field tissue differentiation to identify normal tissue, nerves, blood vessels and tumors in real time. The technology is non-invasive, non-contact and does not require the use of exogenous contrast agent.  Visit website.

ATRO Medical

Presenter

ATRO Medical arrow
arrow
Anita Brinks

COO

ATRO Medical's Artimis prosthesis is intended to provide patients who are too young for a knee replacement yet suffering from chronic knee pain with a viable solution. Artimis is a flexible, artificial meniscus that offers patients a less invasive alternative for treating chronic knee pain. Visit website.

Arga Medtech

Presenter

Arga Medtech arrow
arrow
David Neale

CEO

Arga Medtech is developing a next-generation solution for the treatment of cardiac arrhythmia and atrial fibrillation. The company's Coherent Sine-burst Electroporation (CSE) uses a proprietary puled-field ablation (PFA) generator and catheter to offer a single-shot device capable of producing linear and focal lesions safer, more efficiently and faster than existing technologies used to treat cardiac arrhythmias today. Visit website.

Radiance Therapeutics

Presenter

Radiance Therapeutics arrow
arrow
Laurence Marsteller

CEO

Next-generation beta ophthalmic applicator. Visit website.

INNITIUS

Presenter

INNITIUS arrow
arrow
Ruben Molina

CEO and Co-Founder

INNITIUS is a medical device startup that develops a new technology (Torsional Waves) for the numerical and objective quantification of cervical consistency. This technology is reproducible between different users and, in combination with diagnostic algorithms that include this variable together with other clinical history variables, will be used for the diagnosis of any pathology related to changes in the consistency of cervical tissue in women in the different stages of life globally. The first pathology targeted by the company is the diagnosis of Threatened Preterm Labor. Visit website.

NIMBLE

Presenter

NIMBLE arrow
arrow
Oriol Iborra

CEO & Co-Founder

Every year, 4M new coronary stents are implanted to maintain the arteries’ functionality of patients who suffered a heart attack. However, 30% of these stents will fail within two years, and the sole method available to cardiologists to monitor stent malfunction is an angiogram—an invasive and ionizing procedure performed during surgery. We introduce the NIMBLE System, a first-in-class, non-invasive, non-ionizing microwave-based technology that enables cardiologists to obtain objective data about the status of coronary stents. This includes level of occlusion, potential fractures, or migrations that could endanger patients' lives. NIMBLE addresses a massive blue ocean market of $8 billion, allowing cardiologists to take control of their patients with heart failure, providing objective data through a convenient, non-invasive technology, aiming to save millions of lives. Visit website.

Coramaze Technologies

Presenter

Coramaze Technologies arrow
arrow
Jochen Reinöhl

CEO

Coramaze Technologies is developing an fast end effective solution for the treatment of tricuspid regurgitation. The TriPair system is deigned to be anchored atraumatically to the right atrium. The device is intended to be easily placed in a procedure taking less than twenty minutes, without the need for anesthesia or TEE. TriPair is agnostic of valve morphology and can be retrieved if necessary Visit website.

Twinical

Presenter

Twinical arrow
arrow
Mario Arico

CEO & Co-Founder

Twinical is developing a novel solution for soft-tissue surgical planning and navigation. The company's technology combines artificial intelligence and augmented reality to provide surgeons with digitally-enhanced visual guidance during surgery. Visit website.

Sonic Incytes

Presenter

Sonic Incytes arrow
arrow
Barry Allen

President & CEO

Sonic Incytes' Velacur is a portable, handheld ultrasound that integrates machine learning to enhance image guidance, resulting in a confident assessment of liver health in all body types. Scans using the Velacur system can be performed in the physician office in approximately 5 minutes, producing real-time measurements of liver stiffness and attenuation.  Visit website.

Preventicus

Presenter

Preventicus arrow
arrow
Adriann Hart de Ruijter

Chairman

Preventicus provides managed care programs and technology for cardiovascular disease through early detection, diagnosis and monitoring. Innovative telecare technology, clinical evidence and proven health-economic outcomes, in compliance with medical guidelines, offer value to patients and health insurances Visit website.

machineMD

Presenter

machineMD arrow
arrow
Dominic Senn

CEO

MachineMD’s focus is the creation of automated, quantifiable, and standardized medical examinations to improve the quality and efficiency of healthcare. The company’s mission is to bring the diagnostic quality of trained tertiary care specialists into secondary and primary care sites for the diagnosis and monitoring of neurological disorders. At the core of the company’s approach is the evaluation of biomarkers related to eye movements and pupillary function using artificial intelligence and virtual reality.  Visit website.

Methinks AI

Presenter

Methinks AI arrow
arrow
Pau Rodriguez

CEO

Methinks vision is to provide universal and timely medical assistance to enable life-saving treatments worldwide. The company is initially focused on stroke, the second most common cause of death and a major cause of disability globally. Its AI software, Methinks Stroke Suite, is capable of assisting in stroke triage and providing decision support for life-saving treatment using the simplest medical imaging (non-contrast CT), with the potential to optimize stroke triage and reduce time to treatment. Visit website.

Caresyntax

Presenter

Caresyntax arrow
arrow
Bjoern von Siemens

Founder, CFO

For industry partners bringing innovative solutions to market: Caresyntax offers clinical data services, data science expertise, and AI-enabled tech modules to collect meaningful data straight from the point of care. The company's services capture value for the end-user and produce actionable insights to drive commercial growth and product development needs. Visit website.

What is LSI USA ‘25?
Authentic panels and keynotes with the leaders in Medtech
Sept 19th
How Financial Investors and Strategics Partner in Working With Venture-Backed Startups
image
Nathan Harrington

Managing Partner, Philips Ventures

Philips

image
Carissa Black

Senior Director, Venture Capital

Medtronic

image
Auriel August

Principal

SANTÉ

image
Janke Dittmer

General Partner, Head of European HealthTech Investments

Gilde Healthcare

image
Alexander Schmitz

Partner

Endeavour Vision

Sept 19th
The TechMed Movement Has Arrived: Keynote with Alan Cohen, General Partner at DCVC
image
Alan Cohen

General Partner

DCVC

Sept 18th
Unlocking Disruptive Innovation: Keynote with Dr. Todd Brinton and Dr. Josh Makower
image
Todd Brinton

Board Director, Stanford Biodesign and Co-Founder, Shockwave

Chief Scientific Officer, Edwards Lifesciences

image
Josh Makower

Director & Co-Founder, Stanford Byers Center for Biodesign

Venture Partner, Sofinnova Partners

Sept 18th
Medtech's Conundrum: Where Will Capital and Liquidity Come From?
image
Michael Wasserman

Partner and Chief Operating Officer

Elevage Medical Technologies

image
Alexander Schmitz

Partner

Endeavour Vision

image
Diana Saraceni

Co-Founder & General Partner

Panakes Partners

Sept 18th
Raising Capital from Family Offices
image
Alexei Mlodinow

Former CEO & Co-Founder

SIA

image
Pablo Prieto

Managing Director

CG Health Ventures

image
Tyler Wanke

Investor

Wanke Family Office

image
John Slump

CEO & Co-Founder

Atraverse Medical

Want to Speak on a Panel
With Other Leaders?
Register icon
September 16th - 20th, 2024
Penha Longa Resort, The Ritz Carlton
image
image
image
image
image
image
image
image
image
image
image
image

Sponsorship opportunities

Elevate your brand and
accelerate growth at the
epicenter of the industry

resort
resort
resort
resort

Location Information

Penha Longa Resort The Ritz-Carlton®

The LSI room block at Penha Longa is now closed. A limited number of additional rooms are available at Palacio Estoril and Sheraton Cascais at a discounted LSI rate. Please click on the links below to make your reservation.

Nearby hotel options below
resort icon
Room Block Now Closed

Additional hotel options

Nearby Lodging

carFeatured car 20min
Palácio Estoril Hotel, Golf & Wellness

Complimentary Shuttle

carFeatured car 20min
Sheraton Cascais

Complimentary Shuttle

car 20min
Palacio Seteais

8km from the Venue

car 20min
Intercontinental Cascais

10km from the Venue

car 20min
Onyria Quinta

13km from the Venue

More resources

Resources from the LSI Alumni

Our resource library contains thousands of insightful executive sessions from previous events, captivating photos, and the latest alumni news. Dive in today to prepare for your next LSI experience.

alumni

Activities

Unwind and connect with fellow executives during our social day

Penha Longa Golf Resort

Ranked in the top 30 in Europe with challenging hills, picturesque lakes, and castle towers.

Penha Longa Spa

Exclusive facilities and signature treatments by prestigious luxury brand Natura Bissé.

Historic Circuit

What was once a getaway for Portuguese royalty, guests can explore the resort's sights

Yoga

Improve the health and function of both body and mind with some Yoga or Pilates.

Secure your spot
  • Penha Longa Golf Resort

    Ranked in the top 30 in Europe with challenging hills, picturesque lakes, and castle towers.

  • Penha Longa Spa

    Exclusive facilities and signature treatments by prestigious luxury brand Natura Bissé.

  • Historic Circuit

    What was once a getaway for Portuguese royalty, guests can explore the resort's sights

  • Yoga

    Improve the health and function of both body and mind with some Yoga or Pilates.

partnering

Partnering will soon
open for all registered
attendees

Register below to start building your profile in the app.

playstore appstore
faq faq

Have Questions?
Visit Our FAQ For
More Assistance

View FAQ arrow
business-img

Work with us

Accelerate
your
business

We’re here to help you make smarter decisions
and form stronger partnerships through curated events,
independent market intelligence products and
services, and digital-forward media.